Literature DB >> 535913

Cytotoxicity of glucose analogues in V79 multicell spheroids.

R Sridhar, E C Stroude, W R Inch.   

Abstract

2-Deoxy-D-glucose (2DG) and 5-thio-D-glucose (5TG) are glucose antimetabolites that are known to be selectively toxic to hypoxic cells grown as single cells or as monolayer cultures. These analogues were toxic to Chinese hamster V79 cells grown as multicell spheroids even under aerobic conditions. When spheroids, 500- to 600-microns diameter, were exposed to 7.5 mM of these chemicals for 3 days, the number of clonogenic cells per spheroid dropped to 50% for 5-thio-D-glucose and 20% for 2-deoxy-D-glucose, relative to control values. Survivals were reduced to less than 1% when the experiment was repeated in glucose-free medium. Scanning electron photomicrographs of spheroids treated with 7.5 mM of either analogue showed extensive damage to the outer cells. The cell killing observed was much more than could be predicted on the basis of the hypoxic fraction known to be present in these spheroids. The crowded tumor-like environment may make the cells vulnerable to the cytotoxic action of glucose analogues and other glycolytic inhibitors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 535913     DOI: 10.1007/BF02618247

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  22 in total

1.  The effects of low concentrations of 2-deoxy-D-glucose on the growth, surface architecture, and glycoprotein metabolism of P388 lymphoma cells.

Authors:  M W Myers; A C Sartorelli
Journal:  Biochem Biophys Res Commun       Date:  1975-03-03       Impact factor: 3.575

2.  Effects of glucose analogues (2-deoxy-D-glucose, 2-deoxy-D-galactose) on experimental tumors.

Authors:  J LASZLO; S R HUMPHREYS; A GOLDIN
Journal:  J Natl Cancer Inst       Date:  1960-02       Impact factor: 13.506

3.  The effect of glucose analogues on the metabolism of human leukemic cells.

Authors:  J LASZLO; B LANDAU; K WIGHT; D BURK
Journal:  J Natl Cancer Inst       Date:  1958-09       Impact factor: 13.506

4.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy.

Authors:  L H GRAY; A D CONGER; M EBERT; S HORNSEY; O C SCOTT
Journal:  Br J Radiol       Date:  1953-12       Impact factor: 3.039

5.  Cytotoxicity of two nitroimidazole radiosensitizers in an in vitro tumor model.

Authors:  R Sridhar; C Koch; R Suterland
Journal:  Int J Radiat Oncol Biol Phys       Date:  1976 Nov-Dec       Impact factor: 7.038

6.  Selective chemotherapy of noncycling cells in an in vitro tumor model.

Authors:  R M Sutherland
Journal:  Cancer Res       Date:  1974-12       Impact factor: 12.701

7.  Glucose analogs as potential diagnostic tracers for brain tumors.

Authors:  W Wassenaar; C H Tator; H P Batty
Journal:  Cancer Res       Date:  1975-03       Impact factor: 12.701

8.  Cytotoxic and radiosensitizing effects of 5-thio-D-glucose on hypoxic cells.

Authors:  C W Song; J J Clement; S H Levitt
Journal:  Radiology       Date:  1977-04       Impact factor: 11.105

9.  Effect of metronidazole on the C3H/HeJ mouse and growth of the C3HBA mammary adenocarcinoma.

Authors:  W R Inch; J A McCredie; M J Haynes; R M Sutherland
Journal:  Growth       Date:  1977-03

10.  Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cells.

Authors:  J L Foster; P J Conroy; A J Searle; R L Willson
Journal:  Br J Cancer       Date:  1976-05       Impact factor: 7.640

View more
  6 in total

1.  Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays.

Authors:  Rachel Airley; Andrew Evans; Ali Mobasheri; Stephen M Hewitt
Journal:  Ann Anat       Date:  2010-03-24       Impact factor: 2.698

2.  A theoretical quantitative model for evolution of cancer chemotherapy resistance.

Authors:  Ariosto S Silva; Robert A Gatenby
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

3.  The glycolytic inhibitor 2-deoxyglucose activates multiple prosurvival pathways through IGF1R.

Authors:  Diansheng Zhong; Li Xiong; Tongrui Liu; Xiuju Liu; Xiangguo Liu; Jing Chen; Shi-Yong Sun; Fadlo R Khuri; Yaping Zong; Qinghua Zhou; Wei Zhou
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

Review 4.  Multicellular spheroids. A review on cellular aggregates in cancer research.

Authors:  W Mueller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer.

Authors:  Fakeng Liu; Yuan Liu; Xiuju Liu; Kaisheng Mao; Diansheng Zhong; Adam I Marcus; Fadlo R Khuri; Shi-Yong Sun; Yulong He; Wei Zhou
Journal:  Lung Cancer       Date:  2018-06-23       Impact factor: 5.705

Review 6.  Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics.

Authors:  Rossana Cuciniello; Stefania Filosa; Stefania Crispi
Journal:  J Exp Clin Cancer Res       Date:  2021-12-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.